Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rosuvastatin Gel in Chronic Periodontitis with Type 2 Diabetes
NCT02985099Phase 3Completed
- Sponsor
- Government Dental College and Research Institute
- Start
- Nov 2015
- Primary completion
- Jul 2016
- Modality
- Hydrogel Systems, Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of rosuvastatin 1.2% in situ gel in chronic periodontitis (2 arms), sponsored by Government Dental College and Research Institute. Primary endpoint: Defect Depth Reduction at 9 months. Started Nov 2015; status: completed.
02
Drugs
rosuvastatin 1.2% in situ gel
03
Conditions
chronic periodontitis
Beyond the preview
Go deeper on NCT02985099.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02985099.